CONMED Corporation designs and manufactures medical devices and surgical equipment used in orthopedics, sports medicine, general surgery and gastroenterology. Its portfolio spans arthroscopy and soft-tissue repair tools, electrosurgical systems, insufflation and visualization products, and related instruments for operating rooms and ambulatory surgery centers. Hospitals and surgeons worldwide rely on the brand for procedure-focused capital equipment and single-use disposables.
| Quarter | Revenue | YoY % | Earnings | YoY % |
|---|---|---|---|---|
| Q2 2025 | 342.4 | — | 21.4 | — |
| Q3 2025 | 337.9 | — | 2.9 | — |
| Q4 2025 | 373.2 | — | 16.7 | — |
| Q1 2026 | 317.1 | — | 13.8 | — |
| Q2 2026 | 343.5 | 0.3% | 23.1 | 7.7% |
All markets — KeepWinning global stock screener
Other companies on NYSE: Del Monte Corporation (DMC), Blackrock Municipal 2030 Target Term Trust (BTT), REX American Resources Corporation (REX), BlackRock Capital Allocation Term Trust (BCAT), Adient plc (ADNT), Biglari Holdings Inc. (BH)